Garmin has announced a strategic partnership with Medidata, a provider of cloud-based solutions for clinical research to integrate Garmin’s vívofit activity tracker with Medidata’s Clinical Cloud platform. The integration will optimize clinical trials through mobile health enabling enhanced patient engagement, data quality and operational efficiencies in clinical trials.
Designed to be worn on a person’s wrist 24/7, Garmin’s vívofit water-resistant device measures steps taken, distance, calories burned and hours slept. Utilizing Medidata’s clinical cloud-based platform, data is pulled from the vívofit activity tracker in 15-minute increments and then analyzed to evaluate its connection with traditional clinical measures and determine whether it can provide better insight into patient health status or response to therapy. In doing so, the infrastructure provides life sciences companies with the ability to conduct sophisticated analysis on trial performance.
The vívofit device was an ideal choice for the integration due to its ease of use provided by its year-long battery life. Combined with the convenience and speed associated with capturing direct-from-patient data, the integration has the potential to increase compliance among study participants in a clinical trial setting.
“We’re thrilled to be working with Garmin, a company that shares our passion for innovation and our commitment to enhancing people’s health and well being,” said Glen de Vries, Medidata’s president in a statement. “Integrating the vívofit with the Medidata platform is part of our ongoing efforts to unify mHealth devices with cloud-based technologies in a clinical trial setting. We believe these efforts will result in better data, enhanced patient experiences and more efficient trials.”
Medidata is currently working with top life sciences organizations to explore the feasibility of using the vívofit in clinical trials.